ZBIO: Zenas Biopharma, Inc. Operatsion marja

Ommaviy kompaniya Zenas Corp (ZBIO) logotipi

Zenas Biopharma Inc (ZBIO) Obexelimab sinovlaridan kelib chiqadigan jiddiy klinik tahdidlar va naqd pullarning tez sur'atlarda sarflanishi xavfi bilan yuzlashmoqda. Kompaniyaning daromadlari immunoterapiyani joriy etish hamda buyrak va qalqonsimon bez kasalliklarini davolash uchun antitanalarni sotishga asoslangan. Yetakchi immunologlar jamoasi opsionlar va grantlar orqali rag'batlantirilgan. Operatsion marja tendentsiyasi biznes samaradorligini aks ettiradi, -2747.60 ko'rsatkichi esa asosiy operatsiyalarning daromadli holatini ko'rsatadi.

Zenas Bio (ZBIO): Operatsion faoliyat rentabelligi 14.09.2024dan 20.11.2026gacha

Zenas Biopharma Inc (ZBIO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning dastlabki tahlili:ZBIO, zenasbio.com
Zenas Corp tayyor mahsulotlari

Zenas Biopharma Inc (ZBIO) immunologik agentlarni ishlab chiqadi, ularning kelajakdagi qiymati molekulalarning terapevtik ustunligiga bog'liq. Operatsion marja asosiy biznesning samaradorligini o'lchaydi va foizlar hamda soliqlar to'lanishidan oldingi daromadlar ulushini aks ettiradi. Ushbu ko'rsatkichning o'sishi xarajatlarni optimallashtirish va narxlarni belgilash imkoniyatidan dalolat beradi. Operatsion foyda marjasini tahlil qilish orqali investor modelning barqarorligini baholaydi. Ushbu operatsion foyda marjasining barqarorligi kompaniyaning fundamental hayotiyligini tasdiqlaydi.

Zenas Biopharma Inc raqobatchilari

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|PGEN (Precigen) - Operatsion foyda bo'yicha sotuv rentabelligi|pharming.com (PHAR) - Operatsion rentabellik|Nektar Corp (NKTR) - Operatsion marja|UPB (upstreambio.com) - Operatsion marja|Immunome, Inc. (IMNM) - Operatsion faoliyat rentabelligi|Operatsion marja GOSS|Sotuvning operatsion marjasi KalVista Pharmaceuticals, Inc. KALV|Operatsion rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Sotuvning operatsion rentabelligi|SVRA - Operatsion rentabellik|Rigel Pharmaceuticals - Operatsion foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Operatsion rentabellik|ATXS - Operatsion faoliyat rentabelligi|Operatsion rentabellik enGene Holdings Inc.|RAPT: Operatsion foyda normasi|Operatsion marja JBIO|Sotuvning operatsion marjasi aclaristx.com ACRS|Operatsion rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Sotuvning operatsion rentabelligi|Cabaletta Bio, Inc - Operatsion marja|Sotuvning operatsion rentabelligi Ventyx Biosciences|THTX (theratech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operatsion marja|Sotuvning operatsion rentabelligi Agenus Inc. AGEN|Sotuvning operatsion marjasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operatsion foyda normasi|Operatsion rentabellik atyrpharma.com ATYR|Operatsion marja Adagene Corp ADAG|IMA - Operatsion rentabellik|Operatsion foyda normasi STTK (Shattuck Labs)|EQ: Operatsion marja|Connect Biopharma (CNTB) - Operatsion marja|Operatsion rentabellik Immunic|Operatsion marja atarabio.com|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com